You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET-PTC

Showing 1 - 25 of 211
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Scottsdale, Arizona
  • +84 more
Oct 10, 2022

Low-risk Papillary Thyroid Cancer, Endocrine Malignancy, Thyroid Cancer Trial run by the NCI (Total Thyroidectomy (TT),

Terminated
Has Results
  • Low-risk Papillary Thyroid Cancer
  • +2 more
  • Total Thyroidectomy (TT)
  • Prophylactic central neck lymph node dissection (pCND)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 8, 2022

A Taiwanese Oncogenetic Panel and Integrated Clinical Data

Recruiting
  • Thyroid Cancer
  • A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
  • Kaohsiung, Taiwan
  • +7 more
Sep 12, 2022

Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

Recruiting
  • Nonsmall Cell Lung Cancer
  • HS-10365 capsules
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 22, 2023

Papillary Thyroid Tumors by Mass-ARRAY

Recruiting
  • Papillary Thyroid Cancer
  • Genotyping
  • Milan, MI, Italy
    Istituto Auxologico Italiano
Mar 10, 2023

Galectin-3 in Papillary Thyroid Carcinoma

Not yet recruiting
  • Galactin 3-thyroid Carcinoma
    • (no location specified)
    Jan 26, 2023

    Papillary Thyroid Carcinoma, Thermal Ablation Trial in Beijing (No Intervention)

    Recruiting
    • Papillary Thyroid Carcinoma
    • Thermal Ablation
    • No Intervention
    • Beijing, China
      Beijing Friendship Hospital
    Jul 19, 2023

    Thyroid Carcinoma, Surgery Trial in Groningen (Bevacizumab-IRDye800CW)

    Enrolling by invitation
    • Thyroid Carcinoma
    • Surgery
    • Groningen, Netherlands
      University Medical Center Groningen
    Oct 18, 2023

    Unresectable Melanoma, Metastatic Melanoma Trial in Brussel, Amsterdam, Barcelona (NEO-PTC-01)

    Recruiting
    • Unresectable Melanoma
    • Metastatic Melanoma
    • NEO-PTC-01
    • Brussel, Belgium
    • +2 more
    Dec 5, 2022

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

    Not yet recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +3 more
    • Chang chun, Jilin, China
      Jinlin Province Cancer Hosipital
    Dec 21, 2022

    Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity

    Recruiting
    • Muscle-Invasive Bladder Carcinoma
    • Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Mar 11, 2023

    Thyroid Cancer, Recurrence Trial in Beijing (prophylactic central neck dissection)

    Recruiting
    • Thyroid Cancer
    • Recurrence
    • prophylactic central neck dissection
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Science
    Oct 8, 2023

    Association Between Primary Aldosteronism and Thyroid Cancer

    Completed
    • Thyroid Cancer, Papillary
    • Primary Aldosteronism
    • Secreening test for primary aldosteronism and Confirmatory Testing
    • São Paulo, Brazil
      Ana Alice Wolf Maciel
    Oct 3, 2023

    Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)

    Recruiting
    • Colo-rectal Cancer
    • adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
    • Beijing, China/Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medici
    Aug 4, 2023

    NSCLC Trial in Shanghai (SY-5007)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Sep 4, 2023

    Oxidative Stress and Mitochondrial TERT in Papillary Thyroid

    Recruiting
    • Papillary Thyroid Cancer
      • Milan, Italy
        Istituto Auxologico Italiano
      Mar 2, 2023

      Tumor Deposits for Patients With Papillary Thyroid Carcinoma

      Completed
      • Exploring the Prognostic Value of Tumor Deposits PTC Patients
      • surgery
      • Guangzhou, Guangdong, China
        Nanfang Hospital, Southern Medical University
      Sep 18, 2023

      Advanced Solid Tumor Trial in Los Angeles (EP0031)

      Recruiting
      • Advanced Solid Tumor
      • Los Angeles, California
      • +3 more
      Dec 1, 2022

      Refractory Solid Tumors Trial in Seoul (sunitinib)

      Completed
      • Refractory Solid Tumors
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jun 13, 2022

      Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

      Active, not recruiting
      Has Results
      • Solid Tumor
      • Medullary Thyroid Cancer
      • Guangzhou, Guangdong, China
      • +12 more
      May 9, 2022

      Targeted Therapy to Increase RAI Uptake in Metastatic PTC

      Recruiting
      • Papillary Thyroid Cancer
      • Pediatric Cancer
      • Whole body scan
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Mar 11, 2022

      Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

      Recruiting
      • Hematopoietic and Lymphoid Cell Neoplasm
      • +37 more
      • Birmingham, Alabama
      • +171 more
      Aug 24, 2022

      MDD Trial in Ames (Resistance Exercise Training)

      Active, not recruiting
      • Major Depressive Disorder
      • Resistance Exercise Training
      • Ames, Iowa
        Iowa State University
      Jan 12, 2023

      NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +2 more
      • Shanghai, Shanghai, China
      • +1 more
      Mar 17, 2022